Author name: admin

Phishing Scams Target Ozempic

New research from McAfee reveals a dramatic increase in phishing scams targeting consumers interested in popular weight loss drugs like Ozempic, Wegovy, and Semaglutide. Rising Phishing Scams According to McAfee, a computer and cybersecurity company, phishing scams related to weight loss drugs rose 183% from January to April compared to the previous three months. These […]

Phishing Scams Target Ozempic Read More »

Doctors Warn Against Misuse of Ozempic for Weight Loss

The battle against obesity has long been a public health challenge, prompting the development of various interventions, including lifestyle changes, surgery, and pharmacotherapy. Among the pharmacological options, weight loss drugs such as Ozempic (semaglutide) have recently garnered significant attention for their efficacy. However, their rise has not been without controversy, raising important questions about their

Doctors Warn Against Misuse of Ozempic for Weight Loss Read More »

Novo Nordisk’s CEO to Testify Before U.S. Senate on Drug Pricing

Novo Nordisk, the company behind the blockbuster weight-loss drug Ozempic, has risen to prominence as Europe’s most valuable company in 2023. However, its high U.S. prices have drawn significant scrutiny, prompting CEO Lars Fruergaard Jørgensen to volunteer to testify before the U.S. Senate. Rising Prominence of Novo Nordisk Novo Nordisk has soared to the mantle

Novo Nordisk’s CEO to Testify Before U.S. Senate on Drug Pricing Read More »

HIV & Latinos in the US

Disparities in HIV Infection Rates Among Latinos in the U.S. Despite overall declines, Latinos face higher rates of new HIV infections, with the Southeast showing the highest diagnosis rates. While estimated new HIV infection rates declined 23% in the United States from 2012 to 2022, a KFF Health News-Associated Press analysis found the rate has

HIV & Latinos in the US Read More »

A Weight-Loss Powerhouse Elevating Novo Nordisk’s Market Value

Ozempic Powerhouse For Nova Nordisk Ozempic has become a household name for weight loss, garnering widespread acclaim on social media for its effectiveness. This success has been instrumental in propelling Novo Nordisk (NYSE: NVO) to become one of the most valuable healthcare companies globally, despite the presence of competing drugs. While Novo Nordisk’s achievements to

A Weight-Loss Powerhouse Elevating Novo Nordisk’s Market Value Read More »

Scroll to Top